CRP and rheumatoid arthritis: Considering the above, we propose that molecules from vitamin D metabolism, such as high calcitriol, its hydroxylation efficiency ratio score, and the sVDR in conjunction with high CRP concentrations, could support the existing biomarkers of inflammation and CVD risk in RA patients.